Rapid Micro Biosystems (RPID) FCF Margin (2020 - 2026)

Rapid Micro Biosystems has disclosed FCF Margin across 7 years of filings, most recently posting 193.1% for Q1 2026.

• FCF Margin for Q1 2026 came in at 193.1%, down 6286.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 110.46% (up 2040.0% YoY), and the FY2025 annual result was 95.01%, up 6726.0% from the prior year.
• FCF Margin came in at 193.1% for Q1 2026 at Rapid Micro Biosystems, down from 35.74% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 35.74% in Q4 2025 to a low of 440.0% in Q1 2022.
• The 5-year median for FCF Margin is 153.64% (2023), against an average of 205.91%.
• Across the five-year window, FCF Margin sank 20951 bps in 2022 and jumped 29038 bps in 2023, its largest moves.
• Rapid Micro Biosystems' FCF Margin stood at 143.74% in 2022, then fell by 7 bps to 153.64% in 2023, then grew by 11 bps to 136.85% in 2024, then surged by 74 bps to 35.74% in 2025, then tumbled by 440 bps to 193.1% in 2026.
• The last three FCF Margin figures came in at 193.1% (Q1 2026), 35.74% (Q4 2025), and 115.34% (Q3 2025), per Business Quant data.